dc.creator | Bertoldo, Jean Borges | |
dc.creator | Chiaradia Delatorre, Louise Domeneghini | |
dc.creator | Mascarello, Alessandra | |
dc.creator | Leal, Paulo César | |
dc.creator | Sechini Cordeiro, Marlon Norberto | |
dc.creator | Nunes, Ricardo José | |
dc.creator | Salas Sarduy, Emir | |
dc.creator | Rosenthal, Philip Jon | |
dc.creator | Terenzi, Hernán | |
dc.date.accessioned | 2020-01-23T15:43:46Z | |
dc.date.accessioned | 2022-10-14T23:07:33Z | |
dc.date.available | 2020-01-23T15:43:46Z | |
dc.date.available | 2022-10-14T23:07:33Z | |
dc.date.created | 2020-01-23T15:43:46Z | |
dc.date.issued | 2015-02 | |
dc.identifier | Bertoldo, Jean Borges; Chiaradia Delatorre, Louise Domeneghini; Mascarello, Alessandra; Leal, Paulo César; Sechini Cordeiro, Marlon Norberto; et al.; Synthetic compounds from an in house library as inhibitors of falcipain-2 from Plasmodium falciparum; Taylor & Francis Ltd; Journal of Enzyme Inhibition and Medicinal Chemistry; 30; 2; 2-2015; 299-307 | |
dc.identifier | 1475-6366 | |
dc.identifier | http://hdl.handle.net/11336/95659 | |
dc.identifier | 1475-6374 | |
dc.identifier | CONICET Digital | |
dc.identifier | CONICET | |
dc.identifier.uri | https://repositorioslatinoamericanos.uchile.cl/handle/2250/4317543 | |
dc.description.abstract | Falcipain-2 (FP-2) is a key cysteine protease from the malaria parasite Plasmodium falciparum. Many previous studies have identified FP-2 inhibitors; however, none has yet met the criteria for an antimalarial drug candidate. In this work, we assayed an in-house library of non-peptidic organic compounds, including (E)-chalcones, (E)-N'-benzylidene-benzohydrazides and alkyl-esters of gallic acid, and assessed the activity toward FP-2 and their mechanisms of inhibition. The (E)-chalcones 48, 54 and 66 showed the lowest IC50 values (8.5±0.8μM, 9.5±0.2μM and 4.9±1.3μM, respectively). The best inhibitor (compound 66) demonstrated non-competitive inhibition, and using mass spectrometry and fluorescence spectroscopy assays, we suggest a potential allosteric site for the interaction of this compound, located between the catalytic site and the hemoglobin binding arm in FP-2. We combined structural biology tools and mass spectrometry to characterize the inhibition mechanisms of novel compounds targeting FP-2. | |
dc.language | eng | |
dc.publisher | Taylor & Francis Ltd | |
dc.relation | info:eu-repo/semantics/altIdentifier/url/https://www.tandfonline.com/doi/full/10.3109/14756366.2014.920839 | |
dc.relation | info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.3109/14756366.2014.920839 | |
dc.rights | https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ | |
dc.rights | info:eu-repo/semantics/openAccess | |
dc.subject | FALCIPAIN 2 | |
dc.subject | PLASMODIUM | |
dc.subject | MALARIA | |
dc.subject | CHALCONES | |
dc.title | Synthetic compounds from an in house library as inhibitors of falcipain-2 from Plasmodium falciparum | |
dc.type | info:eu-repo/semantics/article | |
dc.type | info:ar-repo/semantics/artículo | |
dc.type | info:eu-repo/semantics/publishedVersion | |